Literature DB >> 993338

Paraproteinemia: blood hyperviscosity and clinical manifestations.

M A McGrath, R Penny.   

Abstract

Many of the clinical features of paraproteinemia result from impairment of blood flow through the vascular tree because of blood hyperviscosity. Studies were carried out in 65 patients with serum paraproteins (31 with IgG, 25 with IgM, and 9 with IgA) to examine the relationship between the blood viscosity and the frequency of selected clinical features. The blood and plasma viscosities were measured at low rates of shear. Blood hyperviscosity was present in 91% of the patients and plasma hyperviscosity in 75% of the patients. In each of the three immunoglobulin classes both the blood and plasma viscosities increased logarithmically with the paraprotein concentration being greatest in the case of IgM. In addition, the relationship between the hematocrit and the logarithm of blood viscosity tended to be linear at any given protein concentration. In patients with very high levels of paraprotein the blood viscosity was modified by low hematocrits; the latter was below 30 in 70% of patients in whom the concentration of paraprotein was above 4 g/100 ml. The prevalence of clinical complications involving the retinal circulation, the peripheral vascular system, and the central nervous system increased markedly with increasing blood viscosity, measured at 0.18 S-1. One or more of these regions was affected in greater than 80% of patients with blood viscosity above 60 centipoise and in less than 23% of patients with blood viscosity below 40 centipoise. These observations illustrate the complex relationship between blood viscosity, concentration of paraprotein, immunoglobulin class and hematocrit, and emphasize the importance of measuring the whole blood viscosity at low rates of shear in determining the risk of vascular complications.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 993338      PMCID: PMC333283          DOI: 10.1172/JCI108568

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Influence of flow properties of blood upon viscosity-hematocrit relationships.

Authors:  R E WELLS; E W MERRILL
Journal:  J Clin Invest       Date:  1962-08       Impact factor: 14.808

2.  VISCOSITY OF NORMAL HUMAN BLOOD UNDER NORMOTHERMIC AND HYPOTHERMIC CONDITIONS.

Authors:  P W RAND; E LACOMBE; H E HUNT; W H AUSTIN
Journal:  J Appl Physiol       Date:  1964-01       Impact factor: 3.531

3.  SERUM HYPERVISCOSITY SYNDROME.

Authors:  J L FAHEY; W F BARTH; A SOLOMON
Journal:  JAMA       Date:  1965-05-10       Impact factor: 56.272

4.  Immunoelectrophoretic characterization of the serum and urinary proteins in plasma cell myeloma and Waldenstrom's macroglobulinemia.

Authors:  E F OSSERMAN; D LAWLOR
Journal:  Ann N Y Acad Sci       Date:  1961-08-31       Impact factor: 5.691

5.  Kinemicrography of living blood vessels.

Authors:  G P FULTON; B R LUTZ
Journal:  Med Biol Illus       Date:  1957-01

6.  Cold-precipitation by heparin of a protein in rabbit and human plasma.

Authors:  L THOMAS; R T SMITH; R VON KORFF
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

7.  On the shear rate dependence of red cell aggregation in vitro.

Authors:  H Schmid-Schönbein; P Gaehtgens; H Hirsch
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

8.  Waldenström's macroglobulinemia: correlation between expanded plasma volume and increased serum viscosity.

Authors:  M R MacKenzie; E Brown; H H Fudenberg; L Goodenday
Journal:  Blood       Date:  1970-03       Impact factor: 22.113

9.  [Hypervolemia in Waldenström's macroglobulinemia].

Authors:  G Herreman; H Piguet; R Zittoun; G Bilski-Pasquier; J Bousser
Journal:  Nouv Rev Fr Hematol       Date:  1968 Mar-Apr

10.  Blood viscosity in Waldenström's macroglobulinemia.

Authors:  M Mannik
Journal:  Blood       Date:  1974-07       Impact factor: 22.113

View more
  9 in total

1.  Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial disease.

Authors:  T Di Perri; S Forconi; M Guerrini; F L Pasini; R Del Cipolla; C Rossi; D Agnusdei
Journal:  Proc R Soc Med       Date:  1977

2.  [Retinal pigment epithelial detachment in hyperviscosity syndrome].

Authors:  V C Müller; N Mihailovic; C R Clemens; F Alten; N Eter
Journal:  Ophthalmologe       Date:  2018-04       Impact factor: 1.059

Review 3.  Plasmapheresis in paraproteinemia.

Authors:  H H Euler; N Schmitz; H Löffler
Journal:  Blut       Date:  1985-06

4.  Waldenström's macroglobulinemia.

Authors:  C A Ries
Journal:  West J Med       Date:  1988-03

Review 5.  Non-surgical management of peripheral vascular disease: a review.

Authors:  C A Clyne
Journal:  Br Med J       Date:  1980-09-20

6.  [Predictor function of hemorheologic parameters with reference to the incidence of manifest circulatory disorders: Concept of the Aachen study].

Authors:  H Kiesewetter; F Jung; K H Ladwig; E Waterloh; P Roebruck; R Schneider; G Kotitschke; R Bach
Journal:  Klin Wochenschr       Date:  1986-07-15

7.  Blood hyperviscosity with reduced skin blood flow in scleroderma.

Authors:  M A McGrath; R Peek; R Penny
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

8.  A threshold trajectory was revealed by isolating the effects of hemoglobin rate of rise in anemia of chronic kidney disease.

Authors:  Gregory Fusco; Ali Hariri; Carlos Vallarino; Ajay Singh; Peter Yu; Lesley Wise
Journal:  Ther Adv Drug Saf       Date:  2017-07-12

9.  Crystalglobulinemia in Multiple Myeloma: A Rare Case Report of Survival and Renal Recovery.

Authors:  Angela Chou; Christopher Long; Leon Vonthethoff; Shir-Jing Ho; Franziska Pettit; Sunil V Badve
Journal:  Can J Kidney Health Dis       Date:  2020-05-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.